| 000 | 00401nam a2200145Ia 4500 | ||
|---|---|---|---|
| 999 |
_c146562 _d146562 |
||
| 020 | _a0824781171 | ||
| 040 | _cCUS | ||
| 082 |
_a615.1901 _bBER/S |
||
| 245 | 0 |
_aStatistical methodology in the pharmaceutical sciences/ _cedited by Donald A Berry |
|
| 250 | _a1st ed. | ||
| 260 |
_aNew York: _bMarcel Dekker, _c1990. |
||
| 300 | _a578 p. | ||
| 505 | _a Contributors. 1. Basic Principles in Designing and Analyzing Clinical Studies. 2. Bioavailability: Designs and Analysis. 3. Analysis of Repeated-Measures Designs. 4. Dose-Response: Relating Doses and Plasma Levels to Efficacy and Adverse Experiences. 5. Population Models. 6. Linear and Nonlinear Regression. 7. Design and Analysis of Multicenter Trials. 8. Crossover Versus Parallel Designs. 9. Handling Dropouts and Related Issues. 10. Group Sequential Methods in Clinical Trials. 11. Survival Analysis. 12. Robust Data Analysis. 13. Categorical Data Analysis. 14. Causality Assessment for Adverse Drug Reactions. 15. Bayesian Metaanalysis. 16. Inferential Problems in Postmarketing Surveillance. | ||
| 650 | _aDrugs -- Testing -- Statistical methods. | ||
| 650 | _aClinical trials -- Statistical methods. | ||
| 650 | _aPharmacy -- Research -- Statistical methods. | ||
| 700 | _aBerry, Donald A, ed. | ||
| 942 | _cWB16 | ||